MICHAEL ODIBO: Open Payments
NPI 1144496191 · WILMINGTON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$830 in 34 payments from 13 companies in 2025. Trend: 2023 $309 · 2024 $958 · 2025 $830
Food & beverage: $830
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $251 |
| Exact Sciences Corporation | 6 | $118 |
| Corcept Therapeutics | 1 | $101 |
| Novo Nordisk Inc | 5 | $97 |
| Lilly USA, LLC | 4 | $75 |
| ABBVIE INC. | 2 | $36 |
| Vanda Pharmaceuticals Inc. | 2 | $34 |
| Amgen Inc. | 1 | $23 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $23 |
| Abbott Laboratories | 1 | $21 |
Products named: BREZTRI, Cologuard Collection Kit, Korlym, MOUNJARO, AIRSUPRA, FARXIGA, Wegovy, FANAPT.
Industry payments across NC — which companies pay providers there.
